Table 5.
Background Characteristics significantly associated with HPV vaccine acceptability (n = 277).
| P value | OR(u) | 95%CI | |
|---|---|---|---|
| Demographic data | |||
| Higher education level attained | 0.01 | 3.01 | 1.57–5.749 |
| Correct knowledge items relating to HPV infection/ vaccine | |||
| HPV can affect men | 0.01 | 4.87 | 2.62–9.05 |
| HPV can be treated with antibiotics | 0.03 | 2.57 | 1.1–5.99 |
| Best age to receive vaccine | 0.01 | 1.29 | 0.15–11.26 |
| Perceptions regarding HPV infection/ vaccine | |||
| The chance of HPV impacting on health is moderate/high | 0.01 | 2.65 | 1.32–5.35 |
| HPV vaccine effective preventing genital warts | 0.02 | 2.54 | 1.17–5.48 |
| HPV vaccine effective preventing anal/penile cancer | 0.01 | 4.08 | 1.55–10.72 |
| Not effective preventing other STI | 0.01 | 3.96 | 1.36–11.49 |
| HPV vaccine is expensive | 0.07 | 6.45 | 0.85–49.07 |
| Vaccine has side effects | 0.01 | 3.67 | 1.5–8.97 |
Abbreviations: STI, Sexually Transmitted Infection, OR, Odds ratio, CI, confidence interval